Novavax says its Covid vaccine is 90% effective, plans to submit data to FDA in third quarter

[ginfreely]

Novavax says its Covid vaccine is 90% effective, plans to submit data to FDA in third quarter​

PUBLISHED MON, JUN 14 20216:04 AM EDTUPDATED 3 HOURS AGO

Berkeley Lovelace Jr.@BERKELEYJR
SHAREShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email
KEY POINTS

• Biotech firm Novavax said its Covid-19 vaccine was shown to be safe and 90.4% effective overall in a phase three clinical trial.
• It said it plans to file for authorization with the FDA in the third quarter.
• With an abundance of vaccines already available in the United States, it’s possible that the government would donate the Novavax doses to other countries.

https://www.cnbc.com/2021/06/14/nov...-to-submit-data-to-fda-in-third-quarter-.html